A Covid-19 vaccine developed by the biotechnology company Moderna has been found to induce immune responses in all of the volunteers who received it in a Phase 1 study. The image shows Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts.
Stories this photo appears in:
Moderna Coronavirus Vaccine Shows 'Promising' Safety and Immune Response Results in Published Phase 1 Study, But More Research Is Needed
A Covid-19 vaccine developed by the biotechnology company Moderna in partnership with the National Institutes of Health has been found to induce immune responses in all of the volunteers who received it in a Phase 1 study.
